摘要
背景:白藜芦醇可能具有延长生命和健康有益的特性,其中一些可能像研究热量限制(CR)。CR出现延长模型生物的寿命在一些研究中,可能有利于人类健康。然而,对于人类而言,限制一段时间进食似乎不切实际,物质模仿CR的有利影响而不得不减少食物的摄入可以改善健康老龄化和肥胖人群。 方法:我们已经回顾了文献研究白藜芦醇对模型生物的寿命,包括酵母,苍蝇,蠕虫和啮齿动物的影响。我们总结了体内的研究结果,描述调制的分子靶标和基因表达在体内和体外观察,并讨论这些变化可能有助于寿命延长。从临床研究的数据进行了总结,提供了一个洞察白藜芦醇补充人类的潜力。 结果:白藜芦醇的补充已被证明延长寿命约60%的模型生物体进行的研究。然而,目前的文献是矛盾的,表明白藜芦醇的寿命的影响有很大的不同,这取决于模型生物。而蠕虫和鱼似乎很敏感的白藜芦醇,白藜芦醇没有影响的研究在果蝇和小鼠的寿命进行了大部分。此外,如剂量,性别,遗传背景和饮食组成的因素可能会导致观察到的效果的高方差。 结论:它仍然是不确定白藜芦醇是否确实是一个CR模拟具有延长生命的性质。白藜芦醇的生物利用度有限,可能进一步阻碍其潜在的影响。
关键词: 二苯乙烯,caloric longevity,能量限制的限制,mimetic,多酚,红酒。
Current Medicinal Chemistry
Title:Resveratrol and Lifespan in Model Organisms
Volume: 23 Issue: 41
Author(s): Kathrin Pallauf, Gerald Rimbach, Petra Maria Rupp, Dawn Chin, Insa M.A. Wolf
Affiliation:
关键词: 二苯乙烯,caloric longevity,能量限制的限制,mimetic,多酚,红酒。
摘要: Background: Resveratrol may possess life-prolonging and health-benefitting properties, some of which may resemble the effect of caloric restriction (CR). CR appears to prolong the lifespan of model organisms in some studies and may benefit human health. However, for humans, restricting food intake for an extended period of time seems impracticable and substances imitating the beneficial effects of CR without having to reduce food intake could improve health in an aging and overweight population.
Methods: We have reviewed the literature studying the influence of resveratrol on the lifespan of model organisms including yeast, flies, worms, and rodents. We summarize the in vivo findings, describe modulations of molecular targets and gene expression observed in vivo and in vitro, and discuss how these changes may contribute to lifespan extension. Data from clinical studies are summarized to provide an insight about the potential of resveratrol supplementation in humans.
Results: Resveratrol supplementation has been shown to prolong lifespan in approximately 60% of the studies conducted in model organisms. However, current literature is contradictory, indicating that the lifespan effects of resveratrol vary strongly depending on the model organism. While worms and killifish seemed very responsive to resveratrol, resveratrol failed to affect lifespan in the majority of the studies conducted in flies and mice. Furthermore, factors such as dose, gender, genetic background and diet composition may contribute to the high variance in the observed effects.
Conclusion: It remains inconclusive whether resveratrol is indeed a CR mimetic and possesses life-prolonging properties. The limited bioavailability of resveratrol may further impede its potential effects.
Export Options
About this article
Cite this article as:
Kathrin Pallauf, Gerald Rimbach, Petra Maria Rupp, Dawn Chin, Insa M.A. Wolf , Resveratrol and Lifespan in Model Organisms, Current Medicinal Chemistry 2016; 23 (41) . https://dx.doi.org/10.2174/0929867323666161024151233
DOI https://dx.doi.org/10.2174/0929867323666161024151233 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing
Current Gene Therapy MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Oxidative Stress in Diabetic Nephropathy
Current Medicinal Chemistry Subject index to volume 3
Current Molecular Medicine Surgical Ventricular Restoration to Reverse Left Ventricular Remodeling
Current Cardiology Reviews Rheumatoid Arthritis: Cardiovascular Manifestations, Pathogenesis, and Therapy
Current Pharmaceutical Design Serum Endocan, Neuron-Specific Enolase and Ischemia-Modified Albumin Levels in Newborns with Partial Blood Exchange Transfusion
Combinatorial Chemistry & High Throughput Screening Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?
Current Pharmaceutical Design <i>Qiliqiangxin</i> Prescription Promotes Angiogenesis of Hypoxic Primary Rat Cardiac Microvascular Endothelial Cells via Regulating miR-21 Signaling
Current Pharmaceutical Design Cellular Therapy for Heart Failure
Current Cardiology Reviews Mild Mitochondrial Uncoupling as a Therapeutic Strategy
Current Drug Targets Iron and Iron Chelators: A Review on Potential Effects on Skin Aging
Current Aging Science Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry Cellular Mechanisms for Diastolic Dysfunction in the Human Heart
Current Pharmaceutical Biotechnology Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
Current Drug Metabolism The Vascular Endothelin System in Hypertension - Recent Patents and Discoveries
Recent Patents on Cardiovascular Drug Discovery The Role of Combined Assessment of Defense Against Oxidative Stress and Inflammation in the Evaluation of Peripheral Arterial Disease
Current Molecular Medicine Nanocarriers Loaded with Oxygen to Improve the Protection of the Heart to be Transplanted
Current Pharmaceutical Design Management of Patients with Poly-Vascular Disease: Priorities for Revascularization Procedures
Current Vascular Pharmacology The Effects of Erythropoietin on the Respiratory Function: Measurements of Respiratory Mechanics in the Rat
Current Respiratory Medicine Reviews